Journal article
In T2DM with CKD, semaglutide reduced major kidney disease events at 3 y.
Abstract
SOURCE CITATION: Perkovic V, Tuttle KR, Rossing P, et al; FLOW Trial Committees and Investigators. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N Engl J Med. 2024;391:109-121. 38785209.
Authors
Collister D; Pannu N
Journal
Annals of Internal Medicine, Vol. 177, No. 9,
Publisher
American College of Physicians
Publication Date
September 2024
DOI
10.7326/annals-24-01579-jc
ISSN
1056-8751